(Q33903076)

29 July 2017

1 reference

title

Comparative tolerability of sulphonylureas in diabetes mellitus (English)

1 reference

29 July 2017

A D Harrower

1

1 reference

29 July 2017

1 April 2000

1 reference

29 July 2017

1 reference

29 July 2017

22

1 reference

29 July 2017

4

1 reference

29 July 2017

313-320

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200022040-00004

29 July 2017

0 references

cites work

Clinical course of myocardial infarction among diabetic patients

1 reference

12 December 2020

Slow elimination of glyburide in NIDDM subjects.

1 reference

12 December 2020

Therapeutical concentrations of tolbutamide, glibenclamide, gliclazide and gliquidone at different glucose levels: in vitro effects on pancreatic A- and B-cell function

1 reference

12 December 2020

Drug-induced hypoglycemia. A review based on 473 cases

1 reference

12 December 2020

Long-term comparative trial of glibenclamide and chlorpropamide in diet-failed, maturity-onset diabetics

1 reference

12 December 2020

Coronary care for myocardial infarction in diabetics

1 reference

12 December 2020

Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment.

1 reference

12 December 2020

[The relatively frequent incidence of severe sulfonylurea-induced hypoglycemia in the last 25 years in Switzerland. Results of 2 surveys in Switzerland in 1969 and 1984]

1 reference

12 December 2020

Des 4-trans-hydroxy-glibenclamide show hypoglycemic activity?

1 reference

12 December 2020

Roles of chlorpropamide, alcohol and acetaldehyde in determining the chlorpropamide-alcohol flush

1 reference

12 December 2020

Pharmacokinetics of oral antihyperglycaemic agents in patients with renal insufficiency

1 reference

12 December 2020

Experience of coronary care in diabetes

1 reference

12 December 2020

Oral hypoglycemic agents

1 reference

12 December 2020

Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker.

1 reference

12 December 2020

Analysis of long-term experience with tolbutamide (orinase) in the management of diabetes

1 reference

12 December 2020

Drug-Induced Dilutional Hyponatremia

1 reference

12 December 2020

Increased fibrinolytic potential induced by gliclazide in types I and II diabetic patients

1 reference

12 December 2020

Mechanism of chlorpropamide-induced antidiuresis in man: Evidence for release of ADH and enhancement of peripheral action

1 reference

12 December 2020

The crux of the UGDP. Spurious results and biologically inappropriate data analysis

1 reference

12 December 2020

The effect of treatment of moderate hypergly- caemia on the incidence of arterial disease

1 reference

12 December 2020

Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update

1 reference

12 December 2020

To flush or not to flush? Comments on the chlorpropamide-alcohol flush

1 reference

12 December 2020

Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents

1 reference

12 December 2020

Gliclazide alcohol flush

1 reference

12 December 2020

Chlorpropamide-alcohol flushing, aldehyde dehydrogenase activity, and diabetic complications

1 reference

12 December 2020

Rates of hypoglycemia in users of sulfonylureas.

1 reference

12 December 2020

Glibenclamide-associated hypoglycaemia: a report on 57 cases

1 reference

12 December 2020

Vascular complications and long-term administration of oral hypoglycemic agents in patients with diabetes mellitus

1 reference

12 December 2020

Determinants of Hospital Admission and Case Fatality in Diabetic Patients With Myocardial Infarction

1 reference

12 December 2020

Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

1 reference

12 December 2020

Clinical evaluation of glipizide. Results of a multicentric study in Spain

1 reference

12 December 2020

Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing?

1 reference

12 December 2020

Pharmacokinetic disposition of 14C-glyburide in patients with varying renal function

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

The fiftieth anniversary of hypoglycaemic sulphonamides. How did the mother compound work?

1 reference

12 December 2020

The sulfonylurea controversy: more questions from the heart

1 reference

12 December 2020

Drug-induced hypoglycemia. A review of 1418 cases.

1 reference

12 December 2020

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.

1 reference

12 December 2020

Symposium on clinical and experimental effects of sulfonylureas in diabetes mellitus; editorial statement

1 reference

12 December 2020

Effect of chlorpropamide and gliclazide on plasminogen activator activity in vascular walls in patients with maturity onset diabetes

1 reference

12 December 2020

Chlorpropamide-induced hyponatremia: incidence and risk factors

1 reference

12 December 2020

The beta-cell response to oral hypoglycemic agents

1 reference

12 December 2020

Effects of gliclazide on platelet reactivity and free radicals in type II diabetic patients: Clinical assessment

1 reference

12 December 2020

ATP-regulated K+ channels in cardiac muscle

1 reference

12 December 2020

Chlorpropamide-alcohol flushing: a dominantly inherited trait associated with diabetes

1 reference

12 December 2020

The molecular interaction of sulfonylureas with beta-cell ATP-sensitive K(+)-channels.

1 reference

12 December 2020

Cardiovascular effects of sulphonylurea derivatives. Implications for the treatment of NIDDM?

1 reference

12 December 2020

Haemodynamic and other effects of sulphonylurea drugs on the heart

1 reference

12 December 2020

An overview of the safety and tolerance of glimepiride

1 reference

12 December 2020

Pharmacokinetics and biotransformation of chlorpropamide in man

1 reference

12 December 2020

Hypoglycemic activity of glyburide (glibenclamide) metabolites in humans.

1 reference

12 December 2020

Glipizide, a new sulfonylurea in the treatment of diabetes mellitus. Summary of clinical experience in 1064 cases.

1 reference

12 December 2020

Chlorpropamide-alcohol flush: a critical reappraisal

1 reference

12 December 2020

Cardiac ATP-sensitive K+ channels: regulation by intracellular nucleotides and K+ channel-opening drugs

1 reference

12 December 2020

Preventive tolbutamide treatment and arterial disease in mild hyperglycaemia

1 reference

12 December 2020

Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.

1 reference

12 December 2020

Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans

1 reference

12 December 2020

Glimepiride. A review of its use in the management of type 2 diabetes mellitus

1 reference

12 December 2020

Comparative tolerability profiles of oral antidiabetic agents

1 reference

12 December 2020

Chlorpropamide-induced hyponatremia

1 reference

12 December 2020

Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.

1 reference

12 December 2020

Clinical pharmacology of oral antidiabetic agents (second of two parts).

1 reference

12 December 2020

Glucose tolerance and mortality, including a substudy of tolbutamide treatment.

1 reference

12 December 2020

Comparison of secondary failure rate between three second generation sulphonylureas

1 reference

12 December 2020

Clinical pharmacology of oral antidiabetic agents (first of two parts).

1 reference

12 December 2020

Effectiveness of glibenclamide on myocardial ischemic ventricular arrhythmias in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Influence of hypoglycaemic sulphonylureas on the electrophysiological parameters of the heart

1 reference

12 December 2020

UK prospective study of therapies of maturity-onset diabetes. I. Effect of diet, sulphonylurea, insulin or biguanide therapy on fasting plasma glucose and body weight over one year

1 reference

12 December 2020

Operative condition-dependent response of cardiac ATP-sensitive K+ channels toward sulfonylureas

1 reference

12 December 2020

Chlorpropamide--alcohol flush: the case in favour

1 reference

12 December 2020

ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage

1 reference

12 December 2020

Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle

1 reference

12 December 2020

Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction.

1 reference

12 December 2020

Plasma chlorpropamide: a critical factor in chlorpropamide-alcohol flush

1 reference

12 December 2020

Selective unresponsiveness of pancreatic beta-cells to acute sulfonylurea stimulation during sulfonylurea therapy in NIDDM

1 reference

12 December 2020

Sulfonylurea KATP blockade in type II diabetes and preconditioning in cardiovascular disease. Time for reconsideration

1 reference

12 December 2020

Behaviour of chlorpropamide in renal insufficiency and under the effect of associated drug therapy

1 reference

12 December 2020

Myocardial infarction in the diabetic patient

1 reference

12 December 2020

Dual effect of glyburide, an antagonist of KATP channels, on metabolic inhibition-induced Ca2+ loading in cardiomyocytes

1 reference

12 December 2020

Ligand-insensitive state of cardiac ATP-sensitive K+ channels. Basis for channel opening

1 reference

12 December 2020

10.2165/00002018-200022040-00004

Identifiers

DOI

1 reference

PubMed ID

10789825

Dimensions Publication ID

29 July 2017

1038245958

0 references

Fatcat ID

release_pk7ufyf7b5bopo26msztjxghjy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pk7ufyf7b5bopo26msztjxghjy

24 November 2022

mapped directly with Wikidata item

PubMed ID

10789825

1 reference

PubMed ID

10789825